The bill amends the existing law on "Collaborative Pharmacy Practice" to expand the scope of collaborative practice agreements by allowing licensed pharmacists to collaborate not only with physicians but also with other healthcare providers. Key definitions are updated, including the replacement of "physicians" with "providers" in various contexts. A "collaborative practice agreement" is defined as a written and signed agreement that outlines the roles and responsibilities of the involved parties, emphasizing that these agreements should be made in the best interest of public health, adhere to clinical guidelines and standards of care, and be reviewed and signed annually by the parties involved.

The bill also removes the definition of the "collaborative practice committee," which previously consisted of appointed individuals from pharmacy and medical boards to advise on collaborative practice agreements. Furthermore, it provides immunity from civil or criminal liability for the director of health, board members, and their agents when acting in good faith within the scope of their duties. The changes are set to take effect on July 1, 2025.